ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling.

Marian A Ackun-Farmmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.